Alternative therapies for type 2 diabetes

Alternative Medicine Review

Volumn 7, Issue 1, 2002, Pages 45-58

  Dey, Lucy ^a   Attele, Anoja S ^a   Yuan, Chun Su ^a  

^a MC 4028 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; ALOE VERA EXTRACT; ALPHA GLUCOSIDASE INHIBITOR; ANTIDIABETIC AGENT; BIGUANIDE DERIVATIVE; CALCIUM; CHROMIUM; GARLIC EXTRACT; GINSENG EXTRACT; GLIBENCLAMIDE; HERBACEOUS AGENT; INSULIN; MAGNESIUM; MEGLITINIDE; METFORMIN; MOMORDICA CHARANTIA EXTRACT; ONION EXTRACT; PIOGLITAZONE; POTASSIUM; REPAGLINIDE; ROSIGLITAZONE; SULFONYLUREA DERIVATIVE; TOLBUTAMIDE; TRIGONELLA FOENUM GRAECUM EXTRACT; TROGLITAZONE; UNINDEXED DRUG; VACCINIUM MYRTILLUS EXTRACT; VANADIUM; VANADYL SULFATE; ZINC;

ACUPUNCTURE; ALTERNATIVE MEDICINE; ATHEROGENESIS; CLINICAL TRIAL; DIARRHEA; DIET SUPPLEMENTATION; DIET THERAPY; DRUG ACTIVITY; EXERCISE; FATIGUE; GASTROINTESTINAL SYMPTOM; HEALTH CARE SYSTEM; HUMAN; HYDROTHERAPY; HYPERINSULINISM; HYPOGLYCEMIA; LACTIC ACIDOSIS; LIFE EXPECTANCY; MUSCLE WEAKNESS; NAUSEA; NEPHROTOXICITY; NERVOUSNESS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATIENT COMPLIANCE; REVIEW; VAGINA BLEEDING; VERTIGO;

ACUPUNCTURE THERAPY; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; HUMANS; HYDROTHERAPY; HYPOGLYCEMIC AGENTS; PHYTOTHERAPY;

EID: 0036197349     PISSN: 10895159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (108)

1. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus
2. Lilly lecture 1987. The triumvirate: Beta-cell, muscle, liver. A collusion responsible for NIDDM
3. Potential cellular and genetic mechanisms for insulin resistance in common disorders of obesity and diabetes
4. Insulin resistance and pathogenesis of non-insulin dependent diabetes mellitus: Cellular and molecular mechanisms
5. The burden of chronic hyperglycemia
6. Pharmacologic therapy for type 2 diabetes mellitus
7. Prevalence and causes of albuminuria in non-insulin-dependent diabetic patients
8. Effects of weight loss on glucose homeostasis in NIDDM
9. United Kingdom prospective diabetes study 24: A 6-year, randomized, controlled trial comparing sulfonylurea, insulin, and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy
10. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
11. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
12. Effect of insulin on body composition in patients with insulin-dependent and non-insulin-dependent diabetes
13. Clinical practice recommendations 1995. Position statement: Diabetes mellitus and exercise
14. Hematologic, electrolyte, and metabolic disorders
15. Traditional plant medicines as treatments for diabetes
16. Bestimmung des galegins und die antidiabetische wirkung der droge herba galegae
17. Pharmacology and mode of action of the hypoglycemic guanidine derivatives
18. Metformin revisited: Its action and indications for use
19. Ginseng pharmacology: Multiple constituents and multiple actions
20. Agranulocytosis caused by Chinese herbal medicine: Dangers of medications containing aminopyrine and phenylbutazone
21. Gut and brain effects of American ginseng root on brainstem neuronal activities in rats
22. Recent advances on ginseng research in China
23. Effect of ginseng radix on GLUT2 protein content in mouse liver in normal and epinephrine-induced hyperglycemic mice
24. Isolation and hypoglycemic activity of quinquefolans A, B, and C, glycans of Panax quinquefolium roots
25. The physiological effects of Aralia, Panax and Eleutherococcus on exercised rats
26. Partial structure of panaxan A, a hypoglycaemic glycan of Panax ginseng roots
27. Isolation and hypoglycaemic activity of panaxans A, B, C, D, and E, glycans of Panax ginseng roots
28. Isolation and hypoglycemic activity of panaxans Q, R, S, T, and U, glycans of Panax ginseng roots
29. Studies on the mechanism of the hypoglycemic activity of ginsenoside-Rb2 in streptozotocin-diabetic rats
30. Isolation and hypoglycemic activity of panaxans I, J, K and L, glycans of Panax ginseng roots
31. Ginseng therapy in non-insulin-dependent diabetic patients
32. American ginseng (Panax quinquefolius L) reduces postprandial glycemia in nondiabetic subjects and subjects with type 2 diabetes mellitus
33. Effects of tissue cultured of ginseng on gastric secretion and pepsin activity
34. Interactions of ginseng extract, ginseng separated fractions, and some triterpenoid saponins with glucose transporters in sheep erythrocytes
35. Panax ginseng pharmacology: A nitric oxide link?
36. Insulin stimulation of glucose uptake in skeletal muscle and adipose tissue in vivo is NO dependent
37. Effects of hypoglycemic components in ginseng radix on blood insulin level in alloxan diabetic mice and on insulin release from perfused rat pancreas
38. The early phase of glucose-stimulated insulin secretion requires nitric oxide
39. Oestrogen-like effect of ginseng
40. Gin Seng and mastalgia
41. Adverse reactions to ginseng
42. Probable interaction between warfarin and ginseng
43. Interaction of ginseng with phenelzine
44. What do commercial ginseng preparations contain?
45. Maternal use of ginseng and neonatal androgenization
46. Rational phytotherapy
47. Effect of Momordica charantia on the glucose tolerance in maturity onset diabetes
48. Antidiabetic and adaptogenic properties of Momordica charantia extract. An experimental and clinical evaluation
49. Demonstration of the hypoglycemic action of Momordica charantia in a validated animal model of diabetes
50. Clinical trial in patients with diabetes mellitus of an insulin-like compound obtained from plant sources
51. Effect of Momordica charantia on blood glucose level of normal and alloxan-diabetic rabbits
52. Herbal products and supplemental nutrients used in the management of diabetes
53. Effects of Momordica charantia L fruit extract on the testicular function of dog
54. Herbal medications, nutraceuticals, and diabetes
55. Effects of fenugreek seeds on endocrine pancreatic secretions in dogs
56. Glucose-lowering effect of fenugreek in non-insulin dependent diabetics
57. "Maple syrup" urine odor due to fenugreek ingestion
58. Antidiabetic effect of a leaf extract from Gymnema sylvestre in non-insulin-dependent diabetes mellitus patients
59. Use of Gymnema sylvestre leaf extract in the control of blood glucose in insulin-dependent diabetes mellitus
60. Antihyperglycemic effect of onion: Effect on fasting blood sugar and induced hyperglycemia in man
61. Antidiabetic effects of S-allyl cysteine sulphoxide isolated from garlic Allium sativum Linn
62. Letter: Hypoglycemic action of onion and garlic
63. Pancreatic beta-cell regeneration in rats by (-)-epicatechin
64. Functional beta cell regeneration in the islets of pancreas in alloxan-induced diabetic rats by (-)-epicatechin
65. (-)epicatechin as an antidiabetic drug
66. Flexible dose open trial of Vijayasar in cases of newly-diagnosed non-insulin-dependent diabetes mellitus. Indian Council of Medical Research (ICMR), Collaborating Centres, New Delhi
67. Blueberry leaf extract. Physiological and clinical properties in relation to carbohydrate metabolism
68. Anthocyanosides in the treatment of retinopathies
69. Clinical and electroretinographic study on activity of anthocyanosides
70. Materia medica
71. Non-insulin dependent diabetes mellitus in Psammomys obesus is independent of changes in tissue fatty acid composition
72. The antidiabetic activity of aloes: Preliminary clinical and experimental observations
73. Antidiabetic activity of Aloe vera L. juice: II. Clinical trial in diabetes mellitus patients in combination with glibenclamide
74. Antidiabetic activity of Aloe vera L. juice: I. Clinical trial in new cases of diabetes mellitus
75. Aloe vera: A systemic review of its clinical effectiveness
76. Beneficial effect of chromium-rich yeast on glucose tolerance and blood lipids in elderly subjects
77. Selected vitamins and minerals in diabetes
78. Chromium supplements tied to glucose control
79. Chromium occurrence and function in biologic systems
80. Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes
81. Beneficial effect of chromium supplementation on serum triglyceride levels in NIDDM
82. Dietary chromium intake. Freely chosen diets, institutional diet, and individual foods
83. Chromium in a series of Portuguese plants used in the herbal treatment of diabetes
84. Chromium
85. Chromium picolinate
86. Chromium picolinate
87. Oral vanadyl sulfate improves hepatic and peripheral insulin sensitivity in patients with non-insulin-dependent diabetes mellitus
88. Oral vanadyl sulfate improves insulin sensitivity in NIDDM but not in obese nondiabetic subjects
89. Magnesium, potassium and zinc deficiency in subjects with type II diabetes mellitus
90. Hypomagnesemia, a risk factor in diabetic retinopathy
91. A review of treatment of diabetes by acupuncture during the past forty years
92. Changes of plasma insulin level in diabetics treated with acupuncture
93. Diabetes mellitus
94. A review of treatment of diabetes by acupuncture during the past forty years
95. Hot-tub therapy for type 2 diabetes mellitus
96. Hot-tub therapy for type 2 diabetes mellitus. Reply to discussion